Resources by service
Pooled inventory and Just In Time labelling (JTL) meets demand for multiple channels
When a drug returns compelling results during clinical trials, and when the drug has been developed to fulfill an unmet need for a life-threatening disease, regulators may choose to fast track drug approvals. However, when the drug is required for both commercial purposes and continued, extended clinical trial use, the impact on supply and demand processes can be overwhelming.
Pooled inventory and Just In Time labeling (JTL) meets demand for multiple channelsWith a finite drug supply, one oncology-focused pharmaceutical company was faced with running multiple, parallel trials to establish performance across several therapeutic areas – in addition to accommodating the demand for commercialised product.
Download our latest Case Study to find out how Almac Clinical Services used a pooled inventory strategy and a Just In Time labelling (JTL) approach to ensure all studies received the drug quantities needed to best support patients, at the right time, in the right place and without waste.
If you require any further information, please contact Almac Clinical Services.
*By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to info@almacgroup.com. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.
